Loading
Loading…
Loading…
Tender Value
₹50,000
EMD Value
Exempted
Closing Date
31 Aug 2026, 7:00 pm7d left
RE
9785964
GEM/2026/B/7943846
Two Packet Bid
Diclofenac diethylamine 2 Point 32 Percentage W oblque v Quick Penatrating Topical Solution 30 ml b
Dehradun, Uttarakhand
Total value wise evaluation
BOQ
6 documents required · 6 mandatory
2 yrs
₹31
₹2 L
70%
Exempted
Yes
20 Aug 2026
20 Aug 2026
31 Aug 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Diclofenac diethylamine 2 Point 32 Percentage W oblque v Quick Penatrating Topical Solution 30 ml bottle with metered dose spray | 180 | Bott | DEHRADUN | 30 |
| 2 | Tab Isosorbide Dinitrate 10 mg | 600 | No | DEHRADUN | 30 |
| 3 | Cap Omeprazole 20 mg Plus Domperidone 10 mg | 4,500 | No | DEHRADUN | 30 |
| 4 | Permethrin 5 Percentage Tube of 30 gm | 150 | Tube | DEHRADUN | 30 |
| 5 | Mometasone 0 Point 1 Percentage Tube of 10 gm | 150 | Tube | DEHRADUN | 30 |
| 6 | Tab Ondansetron 8 mg | 2,400 | No | DEHRADUN | 30 |
| 7 | Fluticasone Propionate 50 Mcg BP Nasal Spray | 15 | Bott | DEHRADUN | 30 |
| 8 | Azelastine HCL 140 mg Plus Fluticasone Propionate 50 mcg BP Nasal Spray | 60 | Bott | DEHRADUN | 30 |
| 9 | Tab Metformin 0 Point 5 gm | 600 | No | DEHRADUN | 30 |
| 10 | Cream Anti Phelebitis Tube of 20 gm | 150 | Tube | DEHRADUN | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9785964.pdf
GEM_BID • 0.15 MB
na_urgency_re_09_2026-08-20-18-17-51_496db2d84cd87e670d0f807ffad8b282.pdf
BOQ • 0.51 MB
boq_item_sample_file-1_2026-08-20-18-17-51_4a913ce8501ababfeecb8345b3b3b159.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].